NEW HAVEN, Conn.--(BUSINESS WIRE)--Weave Bio, an AI-native life sciences platform company, announced the public release of its flagship offering, AutoIND, and seed funding of $10M co-led by Innovation ...
James M. Wilson, MD, PhD, director of the Gene Therapy Program at the University of Pennsylvania, and a co-founder of Passage Bio. Passage Bio, a developer of gene therapies for rare monogenic CNS ...
Generation Bio, a developer of redosable gene therapies, said today it has closed on a $100 million Series B financing, with proceeds intended to advance its first two treatment candidates through ...
These free and free-tier services and open-source utilities will have your API up and running in no time The rise of RESTful APIs has been met by a rise in tools for creating, testing, and managing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results